2025-07-08 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data, structured as requested.

## Procter & Gamble (PG) Stock Analysis

**0. Executive Summary:**

Procter & Gamble Co. (PG) is a multinational consumer goods corporation. PG's recent performance shows a divergence from the S&P 500, with concerning trends in recent months. While historically strong, recent news and stock volatility suggest caution. Accumulate with long term horizon and small portion.

**1. Performance vs. S&P 500 (VOO):**

*   **Cumulative Return (PG):** 53.24%
*   **Cumulative Return (VOO):** 95.42%
*   **Cumulative Return Difference (PG - VOO):** -42.18%

*   **Disparity Metrics:**
    *   Max Disparity: 29.9
    *   Min Disparity: -43.8
    *   Current Disparity: -43.8
    *   Relative Disparity: 0.0

**Analysis:** PG has significantly underperformed the S&P 500, with a substantial cumulative return difference of -42.18%. The relative disparity indicates PG is currently at its lowest historical underperformance level compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
| :----------- | :------ | :------ | :------ | :---- | :----- |
| 2015-2017  | 21.0%  | 7.9%  | -8.0%  | 0.0   | 215.0  |
| 2016-2018  | 5.0%   | 56.7%  | -13.0%  | 0.1   | 215.1  |
| 2017-2019  | 30.0%  | 56.7%  | 0.0%   | 0.5   | 292.2  |
| 2018-2020  | 38.0%  | 59.1%  | 18.0%  | 0.3   | 325.5  |
| 2019-2021  | 56.0%  | 59.1%  | 8.0%   | 0.3   | 382.7  |
| 2020-2022  | 24.0%  | 74.7%  | 22.0%  | 0.3   | 354.6  |
| 2021-2023  | 30.0%  | 74.7%  | 12.0%  | 0.3   | 342.8  |
| 2022-2024  | 8.0%   | 74.7%  | -17.0%  | 0.3   | 392.2  |
| 2023-2025  | -7.0%  | 71.6%  | -54.0%  | 0.2   | 376.3  |

**Analysis:**

*   **Alpha:** PG's alpha has fluctuated, with recent periods showing significantly negative values, indicating underperformance relative to its risk-adjusted benchmark. The most recent period, 2023-2025, has a very low alpha of -54.0%.
*   **Beta:** The beta consistently remains below 0.5, suggesting lower volatility compared to the market, although the trend is slightly decreasing, which could indicate a weakening relationship with the market.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows significant variability. The recent 2023-2025 period shows a negative growth of -7.0%.
*   **MDD:** Maximum Drawdown (MDD) values are relatively high, particularly in recent years, indicating substantial peak-to-trough declines in value.

**2. Recent Stock Price Movement:**

*   **Current Price:** 160.83
*   **Last Market Data:**
    *   Price: 160.49
    *   Previous Close: 160.83
    *   Change: -0.21
*   **5-Day Moving Average:** 160.31
*   **20-Day Moving Average:** 160.74
*   **60-Day Moving Average:** 162.76

**Analysis:** The stock price is currently below both the 20-day and 60-day moving averages, suggesting a short-term downward trend. The negative change from the previous close reinforces this observation.  The fact that the 5-day moving average is slightly below the 20-day moving average further indicates a recent weakening.

**3. Market Risk Indicators & Expected Return:**

*   **Market Risk Indicator (MRI):** 0.3302 (Low Risk)
*   **RSI:** 43.04
*   **PPO:** 0.08
*   **Hybrid Signal:** cash_3%_Buy 80% of cash (137 shares - Caution - MRI:0.33) (Cash Ratio: 3% on 2025-07-03)
*   **Recent (20-Day) Relative Disparity Change:** 0.0 (Neutral)
*   **Expected Return (%):** 812.0%

**Analysis:**

*   The MRI suggests a 'Low Risk' environment.
*   The RSI of 43.04 suggests the stock is neither overbought nor oversold.
*   The PPO of 0.08 indicates that the stock is trading slightly above its moving averages, suggesting some positive momentum, but not strongly so.
*   The Hybrid Signal suggests buying but with caution, maintaining a 3% cash position.
*   The recent relative disparity change is zero, indicates stable environment, but there is still downside risk.
*   The extremely high expected return of 812.0% should be viewed with caution, as it likely reflects an optimistic model prediction, based on a long-term (2+ years) buy-and-hold strategy.

**4. Recent News & Significant Events:**

*   **2025-07-05:** Major business developments, regulatory changes, or market events.
*   **2025-07-06:** Analyst discussions on performance and outlook within industry and global contexts.
*   **2025-07-08:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-04:** Market experts highlighting both risks and opportunities.

**Analysis:**  Recent news indicates volatility and potential shifts in the company's environment, requiring careful monitoring. The focus on risk and opportunity suggests mixed sentiment.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출        |
| :----------- | :----- | :---------- |
| 2025-04-24 | 1.58 | 19.78 B$   |
| 2025-01-22 | 1.94 | 21.88 B$   |
| 2024-10-18 | 1.65 | 21.74 B$   |
| 2024-04-19 | 1.56 | 20.20 B$   |
| 2025-04-24 | 1.56 | 20.20 B$   |

**Analysis:** The EPS and revenue figures display some variability, with a recent decrease in both metrics. Although it's not enough data to get any insight of recent earning trend, it shows declining earnings.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| :----------- | :--------- | :------------ |
| 2025-03-31 | $19.78B | 50.98%        |
| 2024-12-31 | $21.88B | 52.39%        |
| 2024-09-30 | $21.74B | 52.06%        |
| 2024-06-30 | $20.53B | 49.60%        |
| 2024-03-31 | $20.20B | 51.20%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
| :----------- | :-------- | :------- |
| 2025-03-31 | $52.27B | 7.21%   |
| 2024-12-31 | $51.17B | 9.05%   |
| 2024-09-30 | $51.84B | 7.64%   |
| 2024-06-30 | $50.29B | 6.24%   |
| 2024-03-31 | $50.06B | 7.50%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has seen fluctuations, with the latest quarter showing a decrease. Profit margins have also varied, with the most recent margin being slightly lower than the previous high.
*   **Capital and Profitability:** Equity has generally increased over the past year, while the Return on Equity (ROE) has fluctuated. The most recent ROE is 7.21%, which is lower than the peak of 9.05% observed earlier.

**7. Overall Analysis:**

Procter & Gamble's stock is currently showing signs of underperformance compared to the S&P 500. Recent indicators, including negative alpha and lower revenue and ROE, suggest some challenges. While the company maintains a low-risk profile (according to MRI), recent news highlights volatility.

**Recommendation:** Given the recent underperformance, stock volatility, and the hybrid signal suggesting a cautious buy, it may be wise to accumulate with small portion. The high expected return should be tempered with caution, focusing on a long-term investment horizon.
